ag尊龙z6mg

PHIP


	Shenzhen Hepalink Pharmaceutical Group Co., Ltd.

	YOU SHOULD READ THE WARNING IN THE DOCUMENT.

►	Warning
►	Important
►	Expected Timetable
►	Contents
►	Summary
►	Definitions
►	Glossary of Technical Terms
►	Forward-looking Statements
►	Risk Factors
►	Waivers and Consents from Strict Compliance with the Hong Kong Listing Rules
►	Information about this Document and the [REDACTED]
►	Directors, Supervisors and Parties Involved in the [REDACTED]
►	Corporate Information
►	Industry Overview
►	Regulatory Environment
►	History, Development and Corporate Structure
►	Business
►	Relationship with the Controlling Shareholders
►	Connected Transaction
►	Directors, Supervisors and Senior Management
►	Share Capital
►	Substantial Shareholders
►	[REDACTED]
►	Financial Information
►	Future Plans and Use of [REDACTED]
►	[REDACTED]
►	Structure of the [REDACTED]
►	How to Apply for the [REDACTED]
►	Appendix I - Accountants' Report
►	Appendix IA - Report on Review of Interim Condensed Consolidated Financial Information for the Three Months Ended March 31, 2020
►	Appendix II - [REDACTED]
►	Appendix III - Taxation and Foreign Exchange
►	Appendix IV - Summary of Principal Legal and Regulatory Provisions
►	Appendix V - Summary of Articles of Association
►	Appendix VI - Statutory and General Information
►	Appendix VII - Documents Delivered to the Registrar of Companies in Hong Kong and Available for Inspection